Clinical Trial Update: Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) [Phase 2]

View source ↗

Summary

Phase 2 trial of obeticholic acid in moderately severe alcoholic hepatitis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Naga P. Chalasani | Conditions: Alcoholic Hepatitis | Phase 2 | Status: TERMINATED | Results posted: 2020-01-28